The Legacy Payments Giant Betting Big on Crypto Growth

When a century-old payments brand dives into crypto, it’s more than a headline; it’s a signal.

This move could redefine how digital dollars reach the world’s unbanked and boost long-term investor returns.

Never Miss a Stock Recommendation Again!

We now send our dividend picks right to your phone via text, so you’ll get the same actionable moves without having to open your inbox.

👉 Click here to get our dividend picks by text and keep our content right at your fingertips.

Energy

Something Big Is Bubbling Off Greece’s Coast

Exxon Mobil Corp. (NYSE: XOM) is heading to the waters off western Greece, signing a landmark exploration deal that could reshape Europe’s energy map. The move marks Exxon’s latest step into the eastern Mediterranean, a region quietly becoming the new frontier for natural gas.

For you, that means another player is stepping into Europe’s energy race, one that’s more about strategy than spectacle. Exxon’s project with Energean and Helleniq Energy could start drilling by 2027, setting the stage for a fresh source of European gas supply.

The Mediterranean Makeover

As Europe moves away from Russian energy, the Mediterranean is becoming prime territory for global energy producers. Exxon’s new venture fits right into that story, expanding a regional network that already stretches from Cyprus to Egypt.

This is how a company builds endurance, not headlines. You can feel that focus shift long-term, stable energy beats short-term hype every time.

The Long Game in Europe’s Backyard

This story is about more than gas fields. It’s about how energy giants adapt when politics, geography, and ambition collide. Exxon’s push into Greece isn’t just about supply, it’s about influence and access.

If exploration goes well, the Ionian coast could become one of Europe’s new power anchors. And whether you track oil, gas, or geopolitics, you’re watching a company dig into its next era of dominance — one deep-water well at a time.

XOM currently trades at $117 and pays a dividend of $4.12 per share, a yield of 3.51%.

Pharma

A New Injection Is Turning Heads in the Billion-Dollar Slim-Down War

Eli Lilly & Co. (NYSE: LLY) is doubling down on its weight-loss empire. Its next big contender, eloralintide, is entering late-stage trials after showing an average weight loss of up to 20% in earlier tests. The results? Enough to make competitors sweat before the first syringe even ships.

The new drug mimics amylin, a hormone that regulates appetite and digestion, while also improving blood pressure and reducing inflammation. You can see why Lilly’s betting big, as this isn’t just about slimming; it’s about system-wide health optimization.

When Innovation Becomes a Habit

Lilly’s secret weapon has always been momentum. With Zepbound and Mounjaro already rewriting the rules of modern medicine, this new addition gives the company depth no rival can easily match.

Buyers love a trend, but what they love more is a company that turns trends into pipelines. You might call it evolution by experimentation; every success funds the next leap forward.

The Long Game in a Fast Market

Rivals like Novo Nordisk, Roche, and AbbVie are chasing fast, but Lilly’s already running a different race. It’s building a family of drugs designed to work smarter, last longer, and reach more patients.

If eloralintide delivers what the trials promise, you’ll be watching the start of a new era in obesity treatment with Lilly holding the playbook. And when you think about the future of weight-loss medicine, remember: some companies follow demand, others define it.

LLY currently trades at $913 and pays a dividend of $6.00 per share, a yield of 0.66%.

Rare Signal Detected (Sponsored)

5 Stocks Showing the Same Setup Before Past 200% Runs

A unique technical pattern has reappeared—one analysts say preceded some of the biggest rallies in recent years.

This time, it’s flashing across 5 specific companies with unusual momentum strength.

Each one is backed by rock-solid fundamentals and rising accumulation.

The exclusive report revealing these names is free until midnight tonight.

Don’t miss this rare signal in motion.

[Access your free report now.]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Innovation

The Swoosh Is Now Studying Your Brain

Nike Inc. (NYSE: NKE) has taken a leap of faith with the launch of the Mind platform, a neuroscience-based footwear line that aims to merge physical performance with mental precision.

For years, Nike built its empire on air bubbles, foam chemistry, and biomechanics. Now, it’s shifting gears into the science of cognition, into a frontier that connects movement, mood, and mindset. You can almost feel the pivot from muscle to mind.

When Performance Meets Perception

The project originates from Nike’s newly formed Mind Science Department, a research group that combines neuroscience and athletic design. The company aims to demonstrate that winning begins before the whistle in the brain’s ability to channel rhythm, awareness, and emotion.

For competitors, this is an entirely new challenge. Nike isn’t chasing comfort or speed this time; it’s chasing consciousness. And you can bet that every future sneaker drop will carry a story that feels a little more human.

The Focus Revolution

This bold move could open a new lane in performance wellness — a premium segment centered on recovery, balance, and neural optimization. This isn’t just apparel; it’s behavioral technology wrapped in streetwear.

And as you watch Nike turn the act of focus into a sellable experience, one thing becomes clear: the company that taught the world to “Just Do It” is now teaching it how to think before it does it.

NKE currently trades at $61.00 and pays a dividend of $1.60 per share, a yield of 2.63%.

SNA has lifted its dividend payment to $2.44, a rise of 14.02%. Its new yield is 2.86%. 

NNI has raised its dividend to 33 cents, a boost of 10%. Its new yield is 1.02%. 

TRP has boosted its dividend to 85 cents, an increase of 38.25%. Its new yield is 6.73%. 

CHRW has increased its dividend to 63 cents, a lift of 1.61%. Its new yield is 1.7%. 

FDUS has reduced its dividend to 43 cents, a decrease of 24.56%. Its new yield is 8.32%.

MNR has cut its dividend to 27 cents, a drop of 28.95%. Its new yield is 8.97%.

HUN has cut its dividend to 25 cents, a 65% decline. Its new yield is 4.72%.

Act Fast (Sponsored)

7 Stocks Flashing Strong Buy Signals — Free Report Inside

A new report has identified 7 stocks flashing breakout potential right now.

From more than 4,000 analyzed, only a select few made the cut.

Each one passed strict criteria built on a proven performance system that’s doubled market returns for decades.

These stocks show immediate signs of momentum and could move soon.

The setup window is closing quickly.

Download your free report today before it’s gone.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Everything Else

• Is Comcast Corporation looking to expand its influence in Europe? The media giant’s European pay TV company, Sky, says it’s in talks to buy the media and entertainment unit of commercial free-to-air channel, ITV, in a $2.15 billion deal.

• In pop culture, the return of Starbucks' iconic red holiday cups signifies it's time to look forward to Thanksgiving and trim the Christmas tree. This year, it’s going one better with the launch of a new ‘bearista’ reusable cup, which sold out instantly.

• The $29.99 cups are now being resold for hundreds of dollars online, in a further sign that the coffee chain is regaining relevance after years in the weeds.

  Instagram has been hit with a ‘cease and desist' notice from the Motion

• Picture Association after Meta said it would apply its PG-13 standards to protect younger users from potentially harmful content.